rFPANVAC

Developed for: urinary bladder cancer
Investigated by: National Cancer Institute (NCI) · Rutgers Cancer Institute of New Jersey

today NCT02015104 · Ph 2

20142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT02015104	Dec 2013 → Sep 2018	urinary bladder cancer	National Cancer Institute (NCI)	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	rFPANVAC	“rV-PANVAC (vaccinia) and rFPANVAC (fowlpox) as follows:” NCT02015104 ↗
Route	Subcutaneous	“rF-PANVAC1 x 10(9) pfu SQ at weeks 3, 7, 11, and 15.” NCT02015104 ↗